NovaBay Pharmaceuticals Launches Avenova® Direct on Amazon.com
EMERYVILLE, Calif.–(BUSINESS WIRE)–
Original formulation of Avenova® for the management of bacterial dry eye is now available at an affordable price without a prescription
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Avenova® Direct is available at affordable pricing and without a prescription on Amazon.com through the Company’s new direct-to-consumer online channel. Avenova, the leading lid and lash spray, is designed for the removal of bacteria and debris on and around the eyelid margin that contribute to bacterial eye infections, which represent approximately 85% of the dry eye market. The Avenova Direct page on Amazon.com is available here.
complete press release: finance.yahoo.com/news/novabay-pharmaceuticals-launches-avenova-direct-105000424.html